Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Study Identifies New Potential Target for Treating Vascular Disease
05/03/2023
A recent study has shown that the absence of fragile-X related protein-1 (FXR1) leads to slower VSMC proliferation, increased senescence, and reduced development of scar tissue (neointima). The findings suggest that drugs targeting FXR1 could...
A recent study has shown that the absence of fragile-X related protein-1 (FXR1) leads to slower VSMC proliferation, increased senescence, and reduced development of scar tissue (neointima). The findings suggest that drugs targeting FXR1 could...
A recent study has shown that...
05/03/2023
Cath Lab Digest
News
Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH Study
05/02/2023
PerQseal is the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. It’s placed from inside the vessel, making deployment simpler and more controlled than conventional closure techniques.
PerQseal is the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. It’s placed from inside the vessel, making deployment simpler and more controlled than conventional closure techniques.
PerQseal is the first...
05/02/2023
Cath Lab Digest

Advertisement

News
Philips Extends Company’s Mobile C-Arm Portfolio With Zenition 10
05/02/2023
Royal Philips announced the launch of Philips Image Guided Therapy Mobile C-arm System 1000 – Zenition 10, a new addition to the company’s Zenition mobile C-arm series.
Royal Philips announced the launch of Philips Image Guided Therapy Mobile C-arm System 1000 – Zenition 10, a new addition to the company’s Zenition mobile C-arm series.
Royal Philips announced the...
05/02/2023
Cath Lab Digest
News
Concept Medical Received IDE Approval to Investigate Safety and Efficacy of Its MagicTouch Sirolimus Coated Balloon Catheter for the Treatment of Small Coronary Artery Disease
05/01/2023
The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.  US FDA, on the 25th of...
The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.  US FDA, on the 25th of...
The US FDA has granted an...
05/01/2023
Vascular Disease Management
News
Cook Medical Treats First Patient in First-in-human Clinical Trial for Venous Valve
05/01/2023
Bloomington, Ind. — Cook Medical announces the first patient treated in a clinical study to evaluate a new venous valve designed for treating chronic venous insufficiency. The patient was treated by Dr. Mauricio Alviar, vascular surgeon and...
Bloomington, Ind. — Cook Medical announces the first patient treated in a clinical study to evaluate a new venous valve designed for treating chronic venous insufficiency. The patient was treated by Dr. Mauricio Alviar, vascular surgeon and...
Bloomington, Ind. — Cook Medical...
05/01/2023
Vascular Disease Management

Advertisement

News
Researchers Explore Innovative Treatment Targeting Blood Clots Without Increased Bleeding Risk
04/28/2023
UBC and Michigan scientists adopted an innovative strategy to aim at polyphosphate, a molecule involved in blood clotting that expedites the process but is not a requisite for it.
UBC and Michigan scientists adopted an innovative strategy to aim at polyphosphate, a molecule involved in blood clotting that expedites the process but is not a requisite for it.
UBC and Michigan scientists...
04/28/2023
Cath Lab Digest
News
IN.PACT™ AV DCB Sub-analysis Data Shows Sustained Benefit Through 36 Months; No Difference in Mortality Through 48 Months
04/27/2023
Thursday, April 27, 2023 -- Medtronic today shared additional 36-month data from the IN.PACT AV Access Study, as well as 48-month vital status outcomes. The data was presented by Professor Andrew Holden, director of interventional radiology...
Thursday, April 27, 2023 -- Medtronic today shared additional 36-month data from the IN.PACT AV Access Study, as well as 48-month vital status outcomes. The data was presented by Professor Andrew Holden, director of interventional radiology...
Thursday, April 27, 2023 --...
04/27/2023
Vascular Disease Management
News
10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-World Setting
04/26/2023
Medtronic announced its Endurant™ abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability through proven outcomes in a real-world setting.(1)
Medtronic announced its Endurant™ abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability through proven outcomes in a real-world setting.(1)
Medtronic announced its...
04/26/2023
Cath Lab Digest

Advertisement

News
Bentley Buys Key Suppliers and Engages Employees in Planned IPO
04/21/2023
Acquisition of the Swiss medical technology company Qmedics enables further expansion - planned IPO in Sweden secures independence - 15 million euro incentive program turns employees into shareholders  Hechingen, Friday, April 21,...
Acquisition of the Swiss medical technology company Qmedics enables further expansion - planned IPO in Sweden secures independence - 15 million euro incentive program turns employees into shareholders  Hechingen, Friday, April 21,...
Acquisition of the Swiss medical...
04/21/2023
Vascular Disease Management
News
‘Carb’ Treatment for Stroke Receives New U.S. Patent: Invention Designed to Treat Ischemic Stroke, Protect Brain Tissue from Injury and Minimize Size of Brain Infarct
04/13/2023
Carb, or Carbamathione, [S-(N,N diethylcarbamoyl)glutathioneas], is an active metabolite of disulfiram or DSF, which has been used to treat alcohol use disorder for more than six decades and has been found to be safe with minimum adverse...
Carb, or Carbamathione, [S-(N,N diethylcarbamoyl)glutathioneas], is an active metabolite of disulfiram or DSF, which has been used to treat alcohol use disorder for more than six decades and has been found to be safe with minimum adverse...
Carb, or Carbamathione, [S-(N,N...
04/13/2023
Cath Lab Digest

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use